Clinical Trials Directory

483 clinical trials found.
Gynecologic Cancer

Completing an 8 question survey

Compensation: No
Ages: 18-110
Oncology
Remote/online
Transplant Medicine

We are doing this study to understand how hand transplantation can help you with your daily activities compared to before the transplant.

Compensation: No
Ages: 18-65
Non-Oncology
Duke University Hospital
Volunteer Registries

We are doing this study to better understand how HIV affects the body.

Compensation: No
Ages: 18-110
Non-Oncology
Duke University Hospital
Hematologic Malignancies and Cellular Therapy

The purpose of this study is to find out if combining a bispecific antibody with a drug called selinexor (XPOVIO) is a safe and effective option for multiple myeloma patients whose disease has returned after treatment or did not adequately respond to treatment.

Compensation: No
Ages: 18-110
Oncology
Duke University Hospital
Hematologic Malignancies and Cellular Therapy

We are doing this study to find out if an experimental drug called pacritinib (the study drug) is a safe and effective treatment for people with T-cell lymphoproliferative cancers. We want to know how well it works for patients diagnosed with peripheral T-cell lymphoma (PTCL) or cutaneous T-cell lymphoma (CTCL).

Compensation: No
Oncology
Research for Healthy Adults

We are doing this study to collect blood samples that may be used for the following:

  • To make sure equipment and assays are working properly
  • Staff training
  • Researching assay development (an assay is a laboratory test)

Compensation: No
Ages: 18-110
Non-Oncology
Duke University Hospital
Thoracic Cancer

We are doing this study to find out if an experimental drug called HLX43 (the study drug) is a safe and beneficial option for people with non-small cell lung cancer (NSCLC) that did not respond favorably to standard treatments.

Compensation: No
Ages: 18-110
Oncology
Duke University Hospital, Duke Raleigh Hospital
Blood Disorders

We are doing this study to find out if an experimental drug called etavopivat (the study drug) is a safe and effective option for children and adolescents who have SCD.

Compensation: Yes
Ages: 12-17
Non-Oncology
Other